Rotatorenmanschette

Scheuer, I.

doi:10.1007/978-3-642-76504-9_25

Cited by 2 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Histological assessment of the paired biopsy specimens was performed by an experienced liver histopathologist (BP) who was blinded as to the timing of the specimens. Each was scored according to the degree of portal, lobular and periportal inflammation [16], the presence and severity of fibrosis and the presence of lymphoid aggregates, bile duct damage and fatty infiltration.…”

Section: Methodsmentioning

confidence: 99%

Ribavirin therapy for hepatitis C infection following liver transplantation

et al. 1995

View full text Add to dashboard Cite

Hepatitis C infection following orthotopic liver transplantation may lead to progressive chronic graft dysfunction. In this study, seven liver transplant recipients with chronic allograft dysfunction due to hepatitis C infection (one acquired and six recurrent infections) were treated with oral ribavirin for 6 months. Symptoms of lethargy, nausea and anorexia improved in all patients within 2 weeks of starting the drug, with a fall in serum AST of at least 40% by this time. Ribavirin-induced haemolysis was clinically significant in three patients, necessitating a reduction in the daily dose of ribavirin from 1.2 g to 0.2 g. Comparison of the pre- and post-treatment biopsy specimens in the four patients who tolerated the full dose of ribavirin and who had normal AST levels at the end of 6 months of treatment showed significant histological improvement with reduction in either lobular or periportal inflammation in all of the patients and a reduction in periportal fibrosis in one patient. HCV RNA remained detectable in serum in all of the patients at the end of the study.

show abstract

Section: Methodsmentioning

confidence: 99%

Ribavirin therapy for hepatitis C infection following liver transplantation

et al. 1995

View full text Add to dashboard Cite

show abstract

“…The aromatic iodophenolic ether calicheamicin y,1 is 1,000 times more potent than the clinical anticancer drug adriamycin (381). It seems certain that the near future will see the development of medicinally important organohalogen compounds (496).…”

Section: Discussionmentioning

confidence: 99%

Naturally Occurring Organohalogen Compounds--A Survey

Gribble¹

1992

J. Nat. Prod.

357

199

View full text Add to dashboard Cite

More than 1 5 0 0 different halogenated chemicals are produced and discharged into our biosphere by plants, marine organisms, insects, bacteria, fungi, and other natural processes. In a few cases, the quantities of these naturally occurring halogenated compounds far exceed the amounts of the same chemicals from anthropogenic sources. Furthermore, the evidence is overwhelming that natural enzymatic, thermal, and other processes are constantly occurring in the oceans, in the atmosphere, and in the soil that lead to the formation of chlorinated and brominated phenols and many other halogenated chemicals, including dioxins, that previously were thought only to result from the actions of man. Moreover, it is clear that these natural processes have been producing halogenated compounds and have been an important component of our ecosystem for eons.

show abstract

Rotatorenmanschette

Cited by 2 publications

References 5 publications

Ribavirin therapy for hepatitis C infection following liver transplantation

Ribavirin therapy for hepatitis C infection following liver transplantation

Naturally Occurring Organohalogen Compounds--A Survey

Contact Info

Product

Resources

About